HBM4EU
- Durada
- 2017-2021
- Coordinador
- Marike Kolossa-Gering, Umweltbundesamt (UBA), Germany
- Finançadors
- European Comission (Horizon 2020)
The objective of this new initiative, co-funded by Horizon 2020, is to generate knowledge about human exposure to chemicals in Europe and the potential health impacts of such exposure.
Starting on 1 January 2017, the five-year programme, which has been allocated a budget of more than €74 million, will bring together the work of over 100 European institutions in 26 countries. The Barcelona Institute for Global Health, acting as a third party linked to the Carlos III Health Institute, has been tasked with developing a statistical plan and coordinating the analysis of the data collected.
Biomonitoring allows us to identify and eliminate possible sources of exposure, to study the relationships between pollutants and their health effects, to identify population groups vulnerable to specific pollutants and to prioritise the environmental health research agenda. The knowledge generated by this programme is needed to inform the development and implementation of policies that will effectively safeguard the health of the population.
Altres projectes
Veure projectes passatsProjecte INMA - Infància i Medi Ambient
Born in Bradford
EGG/EAGLE
Early Genetics Growth/Early Genetics and Lifecourse Epidemiology
APACHE
Air Pollution, Autism spectrum disorders, and brain imaging in CHildren amongst Europe
ELFES
LIFECYCLE
Early-life stressors and LifeCycle health
STOP - Childhood Obesity
Science and Technology in childhood Obesity Policy
BiSC (Barcelona Life Study Cohort)
HERA
Integrating Environment and Health Research: a Vision for the EU
ATHLETE
Advancing Tools for Human Early Lifecourse Exposome Research and Translation
MOOD-COVID
Pre- and post-natal Maternal mental health and newbOrn neurOdevelopment during the COVID-19 panDemic
EUCAN-Connect
A federated FAIR platform enabling large-scale analysis of high-value cohort data connecting Europe and Canada in personalized health
OBERON
An integrative strategy of testing systems for identification of EDs related to metabolic disorders